Cargando…

Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus

INTRODUCTION: Epidemiological and genetic studies have recorded the association between proinflammatory cytokines and the development of insulin resistance, diabetes, and cardiovascular disease. The role of interleukin 6 (IL-6), NH2-terminal portion pro-brain natriuretic peptide (NT-proBNP) and resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanem, Samar Ebrahim, Abdel-Samiee, Mohamed, Torky, Mohamed Hamdy, Gaafar, Ahmed, Mohamed, Somia Mokabel, Salah Eldin, Ghada Mohamed Mohamed, Awad, Samah Mohammed, Diab, Karema A, ELsabaawy, Dalia M, Yehia, Sania Ali, Abdelaziz Elbasyouni, Hany Abdelbary, Elshormilisy, Amr Aly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523202/
https://www.ncbi.nlm.nih.gov/pubmed/32988848
http://dx.doi.org/10.1136/bmjdrc-2020-001206
_version_ 1783588342815784960
author Ghanem, Samar Ebrahim
Abdel-Samiee, Mohamed
Torky, Mohamed Hamdy
Gaafar, Ahmed
Mohamed, Somia Mokabel
Salah Eldin, Ghada Mohamed Mohamed
Awad, Samah Mohammed
Diab, Karema A
ELsabaawy, Dalia M
Yehia, Sania Ali
Abdelaziz Elbasyouni, Hany Abdelbary
Elshormilisy, Amr Aly
author_facet Ghanem, Samar Ebrahim
Abdel-Samiee, Mohamed
Torky, Mohamed Hamdy
Gaafar, Ahmed
Mohamed, Somia Mokabel
Salah Eldin, Ghada Mohamed Mohamed
Awad, Samah Mohammed
Diab, Karema A
ELsabaawy, Dalia M
Yehia, Sania Ali
Abdelaziz Elbasyouni, Hany Abdelbary
Elshormilisy, Amr Aly
author_sort Ghanem, Samar Ebrahim
collection PubMed
description INTRODUCTION: Epidemiological and genetic studies have recorded the association between proinflammatory cytokines and the development of insulin resistance, diabetes, and cardiovascular disease. The role of interleukin 6 (IL-6), NH2-terminal portion pro-brain natriuretic peptide (NT-proBNP) and resistin in the pathogenesis of heart disease in type 2 diabetes mellitus (T2DM) is still a matter of controversy. The current study aimed to evaluate the role of these biomarkers in the development of left ventricular systolic dysfunction and the ability to use them as non-invasive test in the prediction of left ventricular hypertrophy and systolic dysfunction in T2DM. RESEARCH DESIGN AND METHODS: 150 participants were included in this case–control study. Patients were divided into two subgroups according to echocardiographic findings: group 1a included 46 patients with type 2 diabetes mellitus and echocardiographic evidence of abnormal systolic function; group 1b included 54 patients with type 2 diabetes mellitus and with normal echocardiogenic study; and group 2 included 50 apparently healthy controls. Routine laboratory investigations such as complete blood count, liver and renal function tests, and lipid profile, serum IL-6, NT-proBNP, and resistin were measured in all participants. Conventional echocardiography was done with special concern on the assessment of left ventricular systolic function (ejection fraction). RESULTS: There was a significant increase in the level of resistin, NT-proBNP and IL-6 in group 1a patients compared with group 1b and in healthy controls. Echocardiographic parameters showed a significant increase in left ventricular mass index, left ventricle posterior wall thickness, interventricular septum thickness, and left ventricle mass in group 1a compared with group 1b and the control group. The increased left ventricular mass index was associated with higher levels of IL-6, NT-proBNP and resistin. CONCLUSIONS: Proinflammatory cytokines had a clear relation with left ventricular systolic dysfunction and hypertrophy and can be used as early non-invasive markers for detection of left ventricular remodeling and systolic dysfunction in patients with T2DM.
format Online
Article
Text
id pubmed-7523202
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75232022020-10-14 Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus Ghanem, Samar Ebrahim Abdel-Samiee, Mohamed Torky, Mohamed Hamdy Gaafar, Ahmed Mohamed, Somia Mokabel Salah Eldin, Ghada Mohamed Mohamed Awad, Samah Mohammed Diab, Karema A ELsabaawy, Dalia M Yehia, Sania Ali Abdelaziz Elbasyouni, Hany Abdelbary Elshormilisy, Amr Aly BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: Epidemiological and genetic studies have recorded the association between proinflammatory cytokines and the development of insulin resistance, diabetes, and cardiovascular disease. The role of interleukin 6 (IL-6), NH2-terminal portion pro-brain natriuretic peptide (NT-proBNP) and resistin in the pathogenesis of heart disease in type 2 diabetes mellitus (T2DM) is still a matter of controversy. The current study aimed to evaluate the role of these biomarkers in the development of left ventricular systolic dysfunction and the ability to use them as non-invasive test in the prediction of left ventricular hypertrophy and systolic dysfunction in T2DM. RESEARCH DESIGN AND METHODS: 150 participants were included in this case–control study. Patients were divided into two subgroups according to echocardiographic findings: group 1a included 46 patients with type 2 diabetes mellitus and echocardiographic evidence of abnormal systolic function; group 1b included 54 patients with type 2 diabetes mellitus and with normal echocardiogenic study; and group 2 included 50 apparently healthy controls. Routine laboratory investigations such as complete blood count, liver and renal function tests, and lipid profile, serum IL-6, NT-proBNP, and resistin were measured in all participants. Conventional echocardiography was done with special concern on the assessment of left ventricular systolic function (ejection fraction). RESULTS: There was a significant increase in the level of resistin, NT-proBNP and IL-6 in group 1a patients compared with group 1b and in healthy controls. Echocardiographic parameters showed a significant increase in left ventricular mass index, left ventricle posterior wall thickness, interventricular septum thickness, and left ventricle mass in group 1a compared with group 1b and the control group. The increased left ventricular mass index was associated with higher levels of IL-6, NT-proBNP and resistin. CONCLUSIONS: Proinflammatory cytokines had a clear relation with left ventricular systolic dysfunction and hypertrophy and can be used as early non-invasive markers for detection of left ventricular remodeling and systolic dysfunction in patients with T2DM. BMJ Publishing Group 2020-09-28 /pmc/articles/PMC7523202/ /pubmed/32988848 http://dx.doi.org/10.1136/bmjdrc-2020-001206 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular and Metabolic Risk
Ghanem, Samar Ebrahim
Abdel-Samiee, Mohamed
Torky, Mohamed Hamdy
Gaafar, Ahmed
Mohamed, Somia Mokabel
Salah Eldin, Ghada Mohamed Mohamed
Awad, Samah Mohammed
Diab, Karema A
ELsabaawy, Dalia M
Yehia, Sania Ali
Abdelaziz Elbasyouni, Hany Abdelbary
Elshormilisy, Amr Aly
Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title_full Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title_fullStr Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title_full_unstemmed Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title_short Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
title_sort role of resistin, il-6 and nh2-terminal portion probnp in the pathogenesis of cardiac disease in type 2 diabetes mellitus
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523202/
https://www.ncbi.nlm.nih.gov/pubmed/32988848
http://dx.doi.org/10.1136/bmjdrc-2020-001206
work_keys_str_mv AT ghanemsamarebrahim roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT abdelsamieemohamed roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT torkymohamedhamdy roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT gaafarahmed roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT mohamedsomiamokabel roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT salaheldinghadamohamedmohamed roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT awadsamahmohammed roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT diabkaremaa roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT elsabaawydaliam roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT yehiasaniaali roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT abdelazizelbasyounihanyabdelbary roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus
AT elshormilisyamraly roleofresistinil6andnh2terminalportionprobnpinthepathogenesisofcardiacdiseaseintype2diabetesmellitus